SCHEMBL5334361

SCHEMBL5334361 is a drug which acts as an agonist at the 5-HT2 family of serotonin receptors, and was developed for the treatment of glaucoma. It is a benzazepine derivative structurally related to the anorectic drug lorcaserin. It is selective for 5-HT2A, with an EC50 of 0.4nM at 5-HT2A vs 3.9nM at 5-HT2C and a much lower affinity of 417nM at 5-HT2B.[1]

SCHEMBL5334361
Identifiers
IUPAC name
  • 7-[(3-methoxyphenoxy)methyl]-2,3,4,5-tetrahydro-1H-3-benzazepine
CAS Number
PubChem CID
Chemical and physical data
FormulaC18H21NO2
Molar mass283.371 g·mol−1
3D model (JSmol)
SMILES
  • COC1=CC(=CC=C1)OCC2=CC3=C(CCNCC3)C=C2
InChI
  • InChI=1S/C18H21NO2/c1-20-17-3-2-4-18(12-17)21-13-14-5-6-15-7-9-19-10-8-16(15)11-14/h2-6,11-12,19H,7-10,13H2,1H3
  • Key:BFCIUKMUJQOSDE-UHFFFAOYSA-N

See also

References
  1. WO 2007149728, Mohapatra S, Hellberg MR, Feng Z, "Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma", assigned to Alcon Manufacturing, Ltd.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.